IL143177A0 - Crystals of 5- [{6- (2-fluorobenzyl) oxy-2-naphthyl} methyl]-2,4-thiazolidinedione - Google Patents
Crystals of 5- [{6- (2-fluorobenzyl) oxy-2-naphthyl} methyl]-2,4-thiazolidinedioneInfo
- Publication number
- IL143177A0 IL143177A0 IL14317799A IL14317799A IL143177A0 IL 143177 A0 IL143177 A0 IL 143177A0 IL 14317799 A IL14317799 A IL 14317799A IL 14317799 A IL14317799 A IL 14317799A IL 143177 A0 IL143177 A0 IL 143177A0
- Authority
- IL
- Israel
- Prior art keywords
- fluorobenzyl
- oxy
- crystals
- methyl
- thiazolidinedione
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33054698 | 1998-11-20 | ||
| PCT/JP1999/006492 WO2000031055A1 (en) | 1998-11-20 | 1999-11-19 | Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL143177A0 true IL143177A0 (en) | 2002-04-21 |
Family
ID=18233859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14317799A IL143177A0 (en) | 1998-11-20 | 1999-11-19 | Crystals of 5- [{6- (2-fluorobenzyl) oxy-2-naphthyl} methyl]-2,4-thiazolidinedione |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6541493B1 (ko) |
| EP (1) | EP1131310B1 (ko) |
| JP (1) | JP3784001B2 (ko) |
| KR (1) | KR100652326B1 (ko) |
| CN (1) | CN1326449A (ko) |
| AT (1) | ATE315552T1 (ko) |
| AU (1) | AU1185100A (ko) |
| BR (1) | BR9916795A (ko) |
| CA (1) | CA2351727C (ko) |
| CZ (1) | CZ20011763A3 (ko) |
| DE (1) | DE69929476T2 (ko) |
| ES (1) | ES2257104T3 (ko) |
| HU (1) | HUP0104139A3 (ko) |
| ID (1) | ID30064A (ko) |
| IL (1) | IL143177A0 (ko) |
| NO (1) | NO20012444L (ko) |
| NZ (1) | NZ512429A (ko) |
| PL (1) | PL348502A1 (ko) |
| PT (1) | PT1131310E (ko) |
| TR (4) | TR200101901T2 (ko) |
| TW (2) | TWI250156B (ko) |
| WO (1) | WO2000031055A1 (ko) |
| ZA (1) | ZA200104081B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1131310E (pt) * | 1998-11-20 | 2006-05-31 | Mitsubishi Chem Corp | Cristais de 5-[{6-(2-fluorobenzil)oxi-2-naftil}metil]-2,4-tiazolidinadiona |
| JP2003514807A (ja) * | 1999-11-19 | 2003-04-22 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 固態形の５−［［６−［（２−フルオロフェニル）メトキシ］−２−ナフタレニル］メチル］−２，４−チアゾリジンジオン |
| JP4590159B2 (ja) * | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法 |
| WO2007049050A2 (en) * | 2005-10-27 | 2007-05-03 | Heptahelix Ab | Modulators of gpr40 for the treatment of diabetes |
| NZ587094A (en) | 2008-02-04 | 2011-07-29 | Pfizer Ltd | Polymorphic form of a [1, 2, 4] triazolo [4, 3-a] pyridine derivative for treating inflammatory diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
| JP2845743B2 (ja) | 1992-12-28 | 1999-01-13 | 三菱化学株式会社 | 新規なナフタレン誘導体 |
| JP4023697B2 (ja) | 1996-11-14 | 2007-12-19 | 三菱化学株式会社 | ナフタレン誘導体の製造方法 |
| PT1131310E (pt) * | 1998-11-20 | 2006-05-31 | Mitsubishi Chem Corp | Cristais de 5-[{6-(2-fluorobenzil)oxi-2-naftil}metil]-2,4-tiazolidinadiona |
-
1999
- 1999-11-19 PT PT99972628T patent/PT1131310E/pt unknown
- 1999-11-19 CA CA002351727A patent/CA2351727C/en not_active Expired - Fee Related
- 1999-11-19 TR TR2001/01901T patent/TR200101901T2/xx unknown
- 1999-11-19 IL IL14317799A patent/IL143177A0/xx unknown
- 1999-11-19 NZ NZ512429A patent/NZ512429A/en unknown
- 1999-11-19 KR KR1020017006299A patent/KR100652326B1/ko not_active IP Right Cessation
- 1999-11-19 ID IDW00200101331A patent/ID30064A/id unknown
- 1999-11-19 CZ CZ20011763A patent/CZ20011763A3/cs unknown
- 1999-11-19 AT AT99972628T patent/ATE315552T1/de not_active IP Right Cessation
- 1999-11-19 US US09/856,295 patent/US6541493B1/en not_active Expired - Fee Related
- 1999-11-19 TR TR2002/02103T patent/TR200202103T2/xx unknown
- 1999-11-19 HU HU0104139A patent/HUP0104139A3/hu unknown
- 1999-11-19 JP JP2000583883A patent/JP3784001B2/ja not_active Expired - Fee Related
- 1999-11-19 TR TR2002/02109T patent/TR200202109T2/xx unknown
- 1999-11-19 DE DE69929476T patent/DE69929476T2/de not_active Expired - Fee Related
- 1999-11-19 BR BR9916795-6A patent/BR9916795A/pt not_active IP Right Cessation
- 1999-11-19 PL PL99348502A patent/PL348502A1/xx unknown
- 1999-11-19 EP EP99972628A patent/EP1131310B1/en not_active Expired - Lifetime
- 1999-11-19 WO PCT/JP1999/006492 patent/WO2000031055A1/en active IP Right Grant
- 1999-11-19 TR TR2002/02110T patent/TR200202110T2/xx unknown
- 1999-11-19 ES ES99972628T patent/ES2257104T3/es not_active Expired - Lifetime
- 1999-11-19 AU AU11851/00A patent/AU1185100A/en not_active Abandoned
- 1999-11-19 CN CN99813380A patent/CN1326449A/zh active Pending
- 1999-11-20 TW TW088120305A patent/TWI250156B/zh not_active IP Right Cessation
- 1999-11-20 TW TW094136910A patent/TWI272944B/zh not_active IP Right Cessation
-
2001
- 2001-05-18 NO NO20012444A patent/NO20012444L/no not_active Application Discontinuation
- 2001-05-18 ZA ZA200104081A patent/ZA200104081B/en unknown
-
2003
- 2003-01-31 US US10/355,160 patent/US20030158241A1/en not_active Abandoned
-
2006
- 2006-02-21 US US11/357,208 patent/US20060149075A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203841A3 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| NZ336271A (en) | Pharmaceutical compositions containing ziprasidone useful in treating psychosis | |
| IL131796A0 (en) | Zinc free insulin crystals for use in pulmonary compositions | |
| ZA925573B (en) | 5-membered heterocyclic compounds processes for preparing them and pharmaceutical compositions containing these compounds | |
| AU2002300661A1 (en) | Method and compositions for the synthesis of BCH-189 and related compounds | |
| ZA936306B (en) | Imidazolidine derivatives | |
| IL113084A0 (en) | Thiazolidine and oxazolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| YU36400A (sh) | Supstituisani tiazolidinedion derivat, postupak za njegovo dobijanje i njegova farmaceutska primena | |
| CA2130174A1 (en) | 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation | |
| HUP0203431A3 (en) | Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same | |
| HUP0103896A3 (en) | Oxygenic heterocyclic compounds pharmaceutical compositions containing them and their use | |
| CA2277890A1 (en) | New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol | |
| AP1441A (en) | Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt. | |
| PL348502A1 (en) | Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione | |
| IL95050A0 (en) | 5-substituted 1,3,4-thiadiazole derivatives,and pesticidal compositions containing the same | |
| DE3568333D1 (en) | Novel 4,5-bis(4-methoxyphenyl)-2-(pyrrol-2-yl)thiazoles, process for the preparation thereof and pharmaceutical composition containing the same | |
| GB8905526D0 (en) | N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same | |
| ZA931593B (en) | 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them. | |
| IL77051A (en) | Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it | |
| EP0256507A3 (en) | 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound | |
| HUT50114A (en) | Herbicide compositions containing halogeno-substituted phenoxy-benzyl-/thio/o/-derivatives as active component and process for producing these compounds | |
| WO1993018059A3 (en) | L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy | |
| HUP9700106A3 (en) | 5-(amino-alkoxy-phenyl)-1,3,4-thiadiazol derivatives, pharmaceutical compositions containing them as active component and process for producing them | |
| IL115269A (en) | Heterocyclic intermediate compounds for use in the preparation of oxazolidinedione and thiazolidinedione derivatives | |
| AU6740187A (en) | Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same |